mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |